BC
REGN icon

Bridgefront Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Bridgefront Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,058
Closed -$1.08M – 787
2025
Q2 		$1.08M Buy
2,058
+1,190
+137% +$664K 0.29% 80
2025
Q1 		$551K Buy
+868
New +$597K 0.16% 228
2024
Q4 		– Sell
-391
Closed -$411K – 751
2024
Q3 		$411K Buy
+391
New +$435K 0.16% 239
2023
Q3 		– Sell
-539
Closed -$387K – 570
2023
Q2 		$387K Buy
+539
New +$416K 0.21% 186
2021
Q3 		– Sell
-1,710
Closed -$955K – 609
2021
Q2 		$955K Sell
1,710
-110
-6% -$55.7K 0.36% 56
2021
Q1 		$861K Buy
1,820
+327
+22% +$159K 0.27% 79
2020
Q4 		$721K Buy
+1,493
New +$806K 0.25% 116

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return